Brokerages expect that Walgreens Boots Alliance (NASDAQ:WBA) will announce $33.56 billion in sales for the current quarter, Zacks reports. Ten analysts have issued estimates for Walgreens Boots Alliance’s earnings. The lowest sales estimate is $31.34 billion and the highest is $34.86 billion. Walgreens Boots Alliance reported sales of $30.12 billion during the same quarter last year, which would suggest a positive year over year growth rate of 11.4%. The company is scheduled to issue its next quarterly earnings report on Thursday, July 5th.
On average, analysts expect that Walgreens Boots Alliance will report full year sales of $130.67 billion for the current year, with estimates ranging from $124.02 billion to $133.29 billion. For the next year, analysts anticipate that the firm will report sales of $137.87 billion per share, with estimates ranging from $127.51 billion to $141.63 billion. Zacks Investment Research’s sales averages are a mean average based on a survey of research analysts that cover Walgreens Boots Alliance.
Walgreens Boots Alliance (NASDAQ:WBA) last issued its quarterly earnings data on Wednesday, March 28th. The pharmacy operator reported $1.73 EPS for the quarter, topping analysts’ consensus estimates of $1.55 by $0.18. The firm had revenue of $33.02 billion during the quarter, compared to analyst estimates of $32.20 billion. Walgreens Boots Alliance had a return on equity of 20.38% and a net margin of 3.33%. The company’s revenue for the quarter was up 12.1% on a year-over-year basis. During the same period in the previous year, the company posted $1.36 EPS.
A number of brokerages have commented on WBA. Leerink Swann reissued a “market perform” rating and set a $70.00 price objective (down from $75.00) on shares of Walgreens Boots Alliance in a report on Wednesday. ValuEngine lowered Walgreens Boots Alliance from a “sell” rating to a “strong sell” rating in a report on Tuesday. BidaskClub raised Walgreens Boots Alliance from a “sell” rating to a “hold” rating in a report on Tuesday, May 1st. Jefferies Group set a $85.00 target price on Walgreens Boots Alliance and gave the company a “buy” rating in a report on Tuesday, April 3rd. Finally, Barclays assumed coverage on Walgreens Boots Alliance in a report on Thursday, March 8th. They issued an “equal weight” rating and a $76.00 target price for the company. Two equities research analysts have rated the stock with a sell rating, nine have assigned a hold rating, thirteen have assigned a buy rating and one has issued a strong buy rating to the stock. Walgreens Boots Alliance currently has a consensus rating of “Buy” and a consensus price target of $82.40.
In related news, Director William C. Foote sold 2,736 shares of the stock in a transaction on Wednesday, May 2nd. The stock was sold at an average price of $65.56, for a total value of $179,372.16. Following the sale, the director now owns 13,679 shares in the company, valued at $896,795.24. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Company insiders own 14.80% of the company’s stock.
Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. 440 Investment Group LLC lifted its holdings in Walgreens Boots Alliance by 1.6% in the fourth quarter. 440 Investment Group LLC now owns 49,341 shares of the pharmacy operator’s stock worth $3,583,000 after buying an additional 780 shares during the period. E&G Advisors LP purchased a new position in Walgreens Boots Alliance in the 4th quarter worth approximately $334,000. MU Investments Co. Ltd. raised its holdings in Walgreens Boots Alliance by 23,757.6% in the 4th quarter. MU Investments Co. Ltd. now owns 78,730 shares of the pharmacy operator’s stock worth $5,743,000 after acquiring an additional 78,400 shares during the last quarter. National Pension Service raised its holdings in Walgreens Boots Alliance by 6.9% in the 4th quarter. National Pension Service now owns 777,632 shares of the pharmacy operator’s stock worth $56,472,000 after acquiring an additional 50,243 shares during the last quarter. Finally, Gateway Investment Advisers LLC raised its holdings in Walgreens Boots Alliance by 8.2% in the 4th quarter. Gateway Investment Advisers LLC now owns 746,358 shares of the pharmacy operator’s stock worth $54,201,000 after acquiring an additional 56,555 shares during the last quarter. Institutional investors and hedge funds own 60.57% of the company’s stock.
WBA traded down $1.01 during midday trading on Friday, reaching $63.22. 207,903 shares of the company were exchanged, compared to its average volume of 4,748,263. The company has a debt-to-equity ratio of 0.44, a quick ratio of 0.45 and a current ratio of 0.90. The firm has a market capitalization of $63.96 billion, a P/E ratio of 12.35, a P/E/G ratio of 1.05 and a beta of 1.15. Walgreens Boots Alliance has a one year low of $61.56 and a one year high of $83.89.
The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 12th. Investors of record on Friday, May 18th will be given a $0.40 dividend. The ex-dividend date of this dividend is Thursday, May 17th. This represents a $1.60 dividend on an annualized basis and a dividend yield of 2.53%. Walgreens Boots Alliance’s dividend payout ratio (DPR) is presently 31.37%.
Walgreens Boots Alliance Company Profile
Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of general merchandise, including non-prescription drugs, beauty products, photo finishing, seasonal merchandise, greeting cards, and convenience foods through its retail drugstores and convenient care clinics.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.